pharma
The April 2020 issue of Pharmafocus is available to read free online now!
April 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, UK, US, coronavirus, generic medicines, pharma, rare disease, real world data, real-world data
The latest monthly edition of Pharmafocus, the April 2020 issue, is available to read for free online now! There’s one …
Lilly partners with Sitryx in $880m immunometabolism drug development deal
April 1, 2020Research and Development Eli Lilly, Sitryx, partnership, pharma
Eli Lilly and UK firm Sitryx have partnered up in a new drug development and commercialisation deal that could potentially …
EUSA Pharma and Ergomed partner to investigate IL-6 targeting in COVID-19 patients with serious respiratory complications
March 31, 2020Manufacturing and Production, Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, pharma
Oncology and rare disease firm EUSA Pharma is aiding in the global fight against the novel coronavirus with the launch …
FDA immunotherapy first with the approval of AZ’s Imfinzi in first-line extensive-stage small cell lung cancer
March 30, 2020Sales and Marketing AstraZeneca, Cancer, FDA, Imfinzi, lung cancer, pharma
AstraZeneca has seized FDA approval for its immune checkpoint inhibitor Imfinzi (durvalumab) in the first-line treatment of extensive-stage small cell …
WHO launches “historic” multinational study to investigate most promising COVID-19 therapies
March 30, 2020Research and Development, Sales and Marketing COVID-19, Gilead, coronavirus, pharma, remdesivir
The World Health Organization continues to push forward in the global fight against the novel coronavirus, and has announced the …
FDA approves BMS’ Zeposia in relapsing multiple sclerosis, but COVID-19 will delay its market entry
March 26, 2020Sales and Marketing Bristol-Myers Squibb, COVID-19, Zeposia, coronavirus, multiple sclerosis, pharma
Bristol-Myers Squibb has secured approval with the FDA for Zeposia (ozanimod) 0.92mg in relapsing forms of multiple sclerosis (RMS), but …
First for Japan with the approval of AstraZeneca’s Lokelma in hyperkalaemia
March 26, 2020Sales and Marketing AstraZeneca, Astra|Zeneca, Japan, Lokelma, hyperkalaemia, pharma
Japan’s Ministry of Health, Labour and Welfare has awarded approval to AstraZeneca’s Lokelma for the treatment of hyerkalaemia, marking the …
Novartis reveals hard-hitting five-year data for its gene therapy Zolgensma in spinal muscular atrophy
March 25, 2020Research and Development Novartis, Zolgensma, gene therapy, pharma, spinal muscular atrophy
Novartis has revealed five-year data on its gene therapy Zolgensma, boasting that the one-time infusion demonstrated “rapid, significant and clinically …
Eyeforpharma Barcelona 2020 is now a free virtual event
March 25, 2020Medical Communications, Research and Development COVID-19, Eyeforpharma Barcelona 2020, coronavirus, events, eyeforpharma, pharma
In light of the rapidly evolving impact of the COVID-19 virus, eyeforpharma has decided to turn eyeforpharma Barcelona 2020 into …
AstraZeneca to leverage Silence Therapeutics’ siRNA expertise in $480mn deal
March 25, 2020Research and Development, Sales and Marketing AstraZeneca, Silence Therapeutics, collaboration, pharma
Silence Therapeutics has revealed it has struck a new collaboration with AstraZeneca which will trigger the “acceleration and re-prioritisation of …
Sustainability and security: How packaging is modernising pharma
March 24, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing counterfeit medicines, falsified medicines, feature, packaging, pharma
In a world living in the shadow of substandard and falsified medicines, climate change and antimicrobial resistance, pharmaceutical packaging will …
Nanovax’s seasonal flu vaccine meets Phase 3 endpoints and matches Sanofi’s Fluzone
March 24, 2020Manufacturing and Production, Research and Development NanoFlu, Nanovax, influenza, pharma
Nanovax has reported positive Phase 3 data for its vaccine NanoFlu, with the candidate meeting its primary endpoints in the …
COVID-19: Gilead freezes compassionate access to remdesivir due to “overwhelming demand”, BMS and Lilly delay new study launches
March 24, 2020Manufacturing and Production, Medical Communications, Research and Development Bristol-Myers Squibb, Eli Lilly, Gilead, Roche, cornavirus, pharma
As national governments continue to ramp up measures to contain the ongoing COVID-19 coronavirus outbreak, so too are pharma and …
FDA turns down label expansion for Jardiance as an adjunct to insulin in type 1 diabetes
March 23, 2020Sales and Marketing FDA, diabetes, jardiance, pharma
The FDA has chosen not to approve an expanded indication of 2.5mg Jardiance (empaglifozin) as an adjunct to insulin in …
ViiV Healthcare scores world-first approval in Canada for monthly HIV regimen Cabenuva
March 23, 2020Sales and Marketing Cabenuva, Canada, HIV, pharma
ViiV Healthcare has secured its first global approval for its once-monthly treatment Cabenuva, it has emerged, to replace current antiretroviral …
Latest content
Five Facts about cardiovascular disease
